Notably, the addition of anti-PD-L1 antibody in pemetrexed-treated coculture system greatly induced splenocyte activation (figure 3A, B), confirming that the effects of the pemetrexed/anti-PD-L1 antibody combinational therapy can also be observed in the mouse tumor models. This evidence concerns the gene CD274 and neoplasm.